War Crimes Tribunal Awaits Karadzic
He is almost unrecognizable in the guise of alternative therapist Dr. Dragan Dabic, but it apparently took more than long hair, a beard and an invented identity to keep former Bosnian Serb leader Radovan Karadzic's past from catching up with him.
He is almost unrecognizable in the guise of alternative therapist Dr. Dragan Dabic, but it apparently took more than long hair, a beard and an invented identity to keep former Bosnian Serb leader Radovan Karadzic’s past from catching up with him. Early Wednesday morning, Karadzic was on his way to The Hague from Belgrade, where his hard-line supporters had rallied against his arrest the night before, to face the United Nations war crimes tribunal for crimes against humanity and genocide during the bloody shelling of Sarajevo and the Srebrenica massacre of 1995.
WAIT, BEFORE YOU GO…AFP:
The wartime Bosnian Serb leader has been indicted on playing a leading role in the siege of Sarajevo and the Srebrenica massacre of some 8,000 Muslim men and boys.
The 43-month siege of Sarajevo claimed more than 10,000 lives.
Karadzic vanished from public view in 1996, the year after the ICTY indicted him for genocide and crimes against humanity.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
There are currently no responses to this article.
Be the first to respond.